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The COVID-19 pandemic has caused 
considerable economic damage 
throughout the world in addition to a 
severe health crisis. Social distancing is the 
main preventative measure for person to 
person transmission of SARS CoV-2.1 This 
has essentially put a halt to all mass partic-
ipation endurance sporting events, with 
road races, triathlons, cycling, Nordic 
skiing and rowing events being indefi-
nitely postponed or cancelled. The bene-
fits of endurance exercise have been 
widely demonstrated,2 therefore, the 
current halt has had significant health and 
social consequences worldwide. From a 
financial perspective, the economic impact 
on the endurance sport mass participation 
industry has also been catastrophic. 
Endurance events are estimated to 
generate over US$3 billion/year in the USA 
alone.3 Taking the example of road 
running, 17.6 million people registered for 
road running events in the USA in 2019.4 
Endurance sports, thanks to the competi-
tion format, allow elite and amateur 
athletes to compete together, attracting 
large crowds of participants (e.g. Henley 
Royal Regatta, Vasaloppet, Gran Fondos, 
International Triathlon Union World 
Championship Grand Final). Therefore, 
the cessation of endurance events 
represents a huge societal loss.
At some point, the pandemic will give 
way to isolated clusters of cases with no 
widespread community transmission and 
people will be able to return to mass 
participation sporting events.5 However, 
until there is a vaccine, a specific cure 
or wide- spread herd immunity, partici-
pation in endurance events will remain 
potentially unsafe and could be consid-
ered socially dangerous. COVID-19 has 
dramatically shifted the focus of medical 
directors to infectious threats, reflecting 
the concerns that endurance mass partic-
ipation events can present specific public 
health challenges because of the gathering 
of large crowds for prolonged periods. 
Furthermore, such events often result in 
mixing of populations that travel to the 
competition destination from different 
parts of the world, thus are exposed to a 
different infectious risk (higher or lower) 
than the hosting local community.
To tackle these challenges the Interna-
tional Institute for Race Medicine and 
World Athletics have gathered represen-
tatives from International Sports Feder-
ations of endurance mass participation 
sporting events (i.e. International Cycling 
Union, International Skiing Federation, 
World Rowing and World Triathlon), to 
form a medical task force. The task force 
also included experts from the Interna-
tional Paralympic Committee and from 
WHO COVID-19 Mass Gatherings 
Expert Group. Representatives from the 
International Olympic Committee and 
WHO were present as observers to ensure 
consistency of preventive measures across 
different mass gathering sectors. Only 
sports that share a high aerobic demand, 
have mass starts or mass arrivals or which 
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focus competition in a relatively small area 
over several days such as rowing regattas, 
were included in the medical task force to 
keep the group uniform. Finally, endur-
ance events planners and stakeholders 
were added as an advisory working group, 
to provide perspective and support to the 
medical task force.
By adapting already existing tools 
developed by WHO6 7 to the character-
istics of endurance mass participation 
sporting events, the medical task force 
created a web- based supporting tool 
for event’s organisers. The Infectious 
Diseases Outbreak Management Tool 
(https:// idom. worldathletics. org/) aims 
to become an accompanying tool for 
endurance mass participation sporting 
events organisers and should help by:
 ► Assessing the risk level of the event 
in both quantitative and qualitative 
manner.
 ► Determining the public health 
and sport event’s mitigation 
preparedness.
 ► Proposing the steps to take to further 
mitigate and reduce the risk.
The tool provides a macroscopic, 
multisport perspective taking into 
consideration local health and safety 
regulations, the individual event’s char-
acteristics and the local community 
needs. It strongly encourages partner-
ship with local and regional health and 
safety agencies, by bringing together the 
specific expertise of the sports bodies 
with that of the local public health 
system.
Based on the principle that a certain 
level of risk will always be present, and on 
a simplified version of WHO Pandemic 
Phase Description,8 the task force intro-
duced the concept of the pendulum of risk 
(figure 1). The pendulum hypothesises 
the existence of three infectious diseases 
outbreak phases, active pandemic, post-
peak/contained outbreak and seasonal 
outbreak, as part of a continuum. There-
fore, the infectivity and transmissibility 
risk of any infectious disease will have to 
be assessed before the organisation of all 
future events.
It is our opinion that the management 
of endurance mass participation sporting 
events during outbreaks can be improved 
from the current situation, so that poten-
tial future outbreaks will not require 
the same scale of countermeasures. The 
continuous understanding of COVID-19 
requires a flexible approach and the 
acknowledgement that all the currently 
available resources should be considered 
as ‘living documents’. It is in the interest 
of the entire endurance event industry 
and of the communities in which these 
events take place, to develop innovative 
strategies to stage events in a way that 
allows the health, economic and social 
benefits to be achieved while reducing 
any outbreak- associated risks.
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